Zydus Cadila announces completion of phase-I trials of malaria drug
NEW DELHI: Ahmedabad-based Zydus Cadila Healthcare has announced that its antimalarial compound ZY19489 (MMV253) in development with Swiss-based product development...
NEW DELHI: Ahmedabad-based Zydus Cadila Healthcare has announced that its antimalarial compound ZY19489 (MMV253) in development with Swiss-based product development...